Product nameAnti-FPR3 antibody [EPR11865]
See all FPR3 primary antibodies
DescriptionRabbit monoclonal [EPR11865] to FPR3
Tested applicationsSuitable for: WB, Flow Cytmore details
Unsuitable for: ICC/IF,IHC-P or IP
Species reactivityReacts with: Human
Does not react with: Mouse, Rat
Synthetic peptide within Human FPR3 aa 1-100 (Cysteine residue). The exact sequence is proprietary.
Database link: P25089
- Human thymus, Jurkat, NCI-H460 cell lysates, NCI-H460 cells
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle.
Storage bufferpH: 7.20
Preservative: 0.01% Sodium azide
Constituents: 9% PBS, 40% Glycerol, 0.05% BSA, 50% Tissue culture supernatant
PurityTissue culture supernatant
Our Abpromise guarantee covers the use of ab172908 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/5000. Predicted molecular weight: 40 kDa.|
|Flow Cyt||1/10 - 1/100.
ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
FunctionLow affinity receptor for N-formyl-methionyl peptides, which are powerful neutrophils chemotactic factors. Binding of FMLP to the receptor causes activation of neutrophils. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system.
Sequence similaritiesBelongs to the G-protein coupled receptor 1 family.
Cellular localizationCell membrane.
- Information by UniProt
- FML2_HUMAN antibody
- FMLP related receptor II antibody
- FMLP-R-II antibody
Flow cytometric analysis of NCI-H460 cells labeling FPR3 with ab172908 (red) or a rabbit IgG (negative) (green).
All lanes : Anti-FPR3 antibody [EPR11865] (ab172908) at 1/1000 dilution
Lane 1 : Human thymus
Lane 2 : Jurkat cell lysate
Lane 3 : NCI-H460 cell lysate
Lysates/proteins at 10 µg per lane.
Predicted band size: 40 kDa
ab172908 has not yet been referenced specifically in any publications.